Open Access
Criteria used to define tumor necrosis factor-alpha inhibitors failure in patients with moderate-to-severe psoriasis: a systematic literature review
Isabel Belinchon Romero
1, 2
,
Almudena Mateu Puchades
3
,
Miguel Ribera Pibernat
4, 5
,
Diana P Ruiz Genao
6
,
Pablo de la Cueva-Dobao
7
,
Jose-Manuel Carrascosa
5, 8
4
Department of Dermatology, Hospital Universitario Parc Taulí, Sabadell, Spain
|
Publication type: Journal Article
Publication date: 2023-04-04
scimago Q1
wos Q1
SJR: 1.204
CiteScore: 6.7
Impact factor: 4.3
ISSN: 07853890, 16512219, 13652060
PubMed ID:
37014135
General Medicine
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
|
|
|
Clinical Epigenetics
1 publication, 50%
|
|
|
Journal of Clinical Medicine
1 publication, 50%
|
|
|
1
|
Publishers
|
1
|
|
|
Springer Nature
1 publication, 50%
|
|
|
MDPI
1 publication, 50%
|
|
|
1
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
2
Total citations:
2
Citations from 2024:
1
(50%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Belinchon Romero I. et al. Criteria used to define tumor necrosis factor-alpha inhibitors failure in patients with moderate-to-severe psoriasis: a systematic literature review // Annals of Medicine. 2023. Vol. 55. No. 1. pp. 1335-1345.
GOST all authors (up to 50)
Copy
Belinchon Romero I., Mateu Puchades A., Ribera Pibernat M., Ruiz Genao D. P., de la Cueva-Dobao P., Carrascosa J. Criteria used to define tumor necrosis factor-alpha inhibitors failure in patients with moderate-to-severe psoriasis: a systematic literature review // Annals of Medicine. 2023. Vol. 55. No. 1. pp. 1335-1345.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1080/07853890.2023.2192957
UR - https://doi.org/10.1080/07853890.2023.2192957
TI - Criteria used to define tumor necrosis factor-alpha inhibitors failure in patients with moderate-to-severe psoriasis: a systematic literature review
T2 - Annals of Medicine
AU - Belinchon Romero, Isabel
AU - Mateu Puchades, Almudena
AU - Ribera Pibernat, Miguel
AU - Ruiz Genao, Diana P
AU - de la Cueva-Dobao, Pablo
AU - Carrascosa, Jose-Manuel
PY - 2023
DA - 2023/04/04
PB - Taylor & Francis
SP - 1335-1345
IS - 1
VL - 55
PMID - 37014135
SN - 0785-3890
SN - 1651-2219
SN - 1365-2060
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2023_Belinchon Romero,
author = {Isabel Belinchon Romero and Almudena Mateu Puchades and Miguel Ribera Pibernat and Diana P Ruiz Genao and Pablo de la Cueva-Dobao and Jose-Manuel Carrascosa},
title = {Criteria used to define tumor necrosis factor-alpha inhibitors failure in patients with moderate-to-severe psoriasis: a systematic literature review},
journal = {Annals of Medicine},
year = {2023},
volume = {55},
publisher = {Taylor & Francis},
month = {apr},
url = {https://doi.org/10.1080/07853890.2023.2192957},
number = {1},
pages = {1335--1345},
doi = {10.1080/07853890.2023.2192957}
}
Cite this
MLA
Copy
Belinchon Romero, Isabel, et al. “Criteria used to define tumor necrosis factor-alpha inhibitors failure in patients with moderate-to-severe psoriasis: a systematic literature review.” Annals of Medicine, vol. 55, no. 1, Apr. 2023, pp. 1335-1345. https://doi.org/10.1080/07853890.2023.2192957.